This Article  • Full text  • PDF  • JAMA News Video  • Author in the Room Audio  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (52)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Women's Health, Other  • Prognosis/ Outcomes  • Cardiovascular Disease/ Myocardial Infarction  • Author in the Room  • Alert me on articles by topic

The Reynolds Risk Score

Paul M Ridker, MD, MPH; Julie E. Buring, ScD; Nader Rifai, PhD; Nancy R. Cook, ScD

JAMA. 2007;297:611-619.

Context  Despite improved understanding of atherothrombosis, cardiovascular prediction algorithms for women have largely relied on traditional risk factors.

Objective  To develop and validate cardiovascular risk algorithms for women based on a large panel of traditional and novel risk factors.

Design, Setting, and Participants  Thirty-five factors were assessed among 24 558 initially healthy US women 45 years or older who were followed up for a median of 10.2 years (through March 2004) for incident cardiovascular events (an adjudicated composite of myocardial infarction, ischemic stroke, coronary revascularization, and cardiovascular death). We used data among a random two thirds (derivation cohort, n = 16 400) to develop new risk algorithms that were then tested to compare observed and predicted outcomes in the remaining one third of women (validation cohort, n = 8158).

Main Outcome Measure  Minimization of the Bayes Information Criterion was used in the derivation cohort to develop the best-fitting parsimonious prediction models. In the validation cohort, we compared predicted vs actual 10-year cardiovascular event rates when the new algorithms were compared with models based on covariates included in the Adult Treatment Panel III risk score.

Results  In the derivation cohort, a best-fitting model (model A) and a clinically simplified model (model B, the Reynolds Risk Score) had lower Bayes Information Criterion scores than models based on covariates used in Adult Treatment Panel III. In the validation cohort, all measures of fit, discrimination, and calibration were improved when either model A or B was used. For example, among participants without diabetes with estimated 10-year risks according to the Adult Treatment Panel III of 5% to less than 10% (n = 603) or 10% to less than 20% (n = 156), model A reclassified 379 (50%) into higher- or lower-risk categories that in each instance more accurately matched actual event rates. Similar effects were achieved for clinically simplified model B limited to age, systolic blood pressure, hemoglobin A_1c if diabetic, smoking, total and high-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and parental history of myocardial infarction before age 60 years. Neither new algorithm provided substantive information about women at very low risk based on the published Adult Treatment Panel III score.

Conclusion  We developed, validated, and demonstrated highly improved accuracy of 2 clinical algorithms for global cardiovascular risk prediction that reclassified 40% to 50% of women at intermediate risk into higher- or lower-risk categories.

Author Affiliations: Donald W. Reynolds Center for Cardiovascular Research and the Center for Cardiovascular Disease Prevention (Drs Ridker, Cook, and Buring), Division of Preventive Medicine (Drs Ridker, Buring, and Cook), and the Division of Cardiovascular Diseases (Dr Ridker), Brigham and Women's Hospital, Boston, Mass, and the Department of Laboratory Medicine, Children's Hospital, Boston, Mass (Dr Rifai).

RELATED LETTERS

Algorithms for Assessing Cardiovascular Risk in Women
Michael J. Pencina, Ramachandran S. Vasan, and Ralph B. D’Agostino, Sr
JAMA. 2007;298(2):175-176.
EXTRACT | FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Thomas J. Wang, Sekar Kathiresan, and Donald M. Lloyd-Jones
JAMA. 2007;298(2):176.
EXTRACT | FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Richard Stevens and Ruth Coleman
JAMA. 2007;298(2):176-177.
EXTRACT | FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Lori B. Daniels, Ori Ben-Yehuda, and Alan S. Maisel
JAMA. 2007;298(2):177.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Further Improvements in CHD Risk Prediction for Women
Roger S. Blumenthal, Erin D. Michos, and Khurram Nasir
JAMA. 2007;297(6):641-643.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Time for Cardiovascular Inflammation Reduction Trials Has Arrived: How Low to Go for hsCRP?
Ridker
Arterioscler. Thromb. Vasc. Bio. 2008;28:1222-1224.
FULL TEXT  

High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of Japanese: The Hisayama Study
Arima et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1385-1391.
ABSTRACT | FULL TEXT  

Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer-Norfolk Cohort: Does Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart Disease Events?
Simmons et al.
Arch Intern Med 2008;168:1209-1216.
ABSTRACT | FULL TEXT  

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius et al.
NEJM 2008;358:2107-2116.
ABSTRACT | FULL TEXT  

The year in atherothrombosis.
Sanz et al.
J Am Coll Cardiol 2008;51:944-955.
FULL TEXT  

Current diagnostic concepts to detect coronary artery disease in women
Stangl et al.
Eur Heart J 2008;29:707-717.
ABSTRACT | FULL TEXT  

Can Fishing for New Genes Catch Patients at Risk of Coronary Artery Disease?
Emmerich and Ridker
Clin. Chem. 2008;54:453-455.
FULL TEXT  

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D'Agostino et al.
Circulation 2008;117:743-753.
ABSTRACT | FULL TEXT  

Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk
Pradhan et al.
Circulation 2008;117:823-831.
ABSTRACT | FULL TEXT  

New cardiovascular risk determinants do exist and are clinically useful
Smulders et al.
Eur Heart J 2008;29:436-440.
ABSTRACT | FULL TEXT  

New cardiovascular risk factors exist, but are they clinically useful?
Wang
Eur Heart J 2008;29:441-444.
ABSTRACT | FULL TEXT  

High-Sensitivity C-Reactive Protein as a Predictor of All-Cause Mortality: Implications for Research and Patient Care
Ridker
Clin. Chem. 2008;54:234-237.
FULL TEXT  

Rationale, Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women
Ridker et al.
Clin. Chem. 2008;54:249-255.
ABSTRACT | FULL TEXT  

A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.
Shiffman et al.
J Am Coll Cardiol 2008;51:444-448.
ABSTRACT | FULL TEXT  

A prospective study of weight change and systemic inflammation over 9 y
Fogarty et al.
Am. J. Clin. Nutr. 2008;87:30-35.
ABSTRACT | FULL TEXT  

Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard and Libby
Clin. Chem. 2008;54:24-38.
ABSTRACT | FULL TEXT  

Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve
Cook
Clin. Chem. 2008;54:17-23.
ABSTRACT | FULL TEXT  

Early Breast Cancer Therapy and Cardiovascular Injury
Jones et al.
J Am Coll Cardiol 2007;50:1435-1441.
ABSTRACT | FULL TEXT  

The Year in Non ST-Segment Elevation Acute Coronary Syndrome
Giugliano and Braunwald
J Am Coll Cardiol 2007;50:1386-1395.
FULL TEXT  

Predicting Stroke Risk in Patients With Atrial Fibrillation
Hackam
Stroke 2007;38:2409-2409.
FULL TEXT  

Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective
Valdez et al.
Pediatrics 2007;120:S78-S86.
ABSTRACT | FULL TEXT  

Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA)
Nasir et al.
Circulation 2007;116:619-626.
ABSTRACT | FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Pencina et al.
JAMA 2007;298:175-176.
FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Wang et al.
JAMA 2007;298:176-176.
FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Daniels et al.
JAMA 2007;298:177-177.
FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Stevens and Coleman
JAMA 2007;298:176-177.
FULL TEXT  

Cardiovascular Biomarkers: Added Value With an Integrated Approach?
Koenig
Circulation 2007;116:3-5.
FULL TEXT  

Other articles noted
Evid. Based Med. 2007;12:95-96.
FULL TEXT  

C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus
Ridker
J Am Coll Cardiol 2007;49:2129-2138.
ABSTRACT | FULL TEXT  

Biomarkers for Prediction of Cardiovascular Events
Musunuru et al.
NEJM 2007;356:1472-1475.
FULL TEXT  

New Algorithm for Cardiovascular Risk
JWatch Women's Health 2007;2007:3-3.
FULL TEXT  

Primary Prevention of Atherosclerotic Cardiovascular Disease: The High Public Burden of Low Individual Risk
Lauer
JAMA 2007;297:1376-1378.
FULL TEXT  

Further Improvements in CHD Risk Prediction for Women
Blumenthal et al.
JAMA 2007;297:641-643.
FULL TEXT  

A New Model for Predicting Cardiovascular Risk in Women?
Journal Watch Cardiology 2007;2007:1-1.
FULL TEXT